# Martin Tolar

> Martin Tolar is a startup investor at Advance Healthcare Management Institute (Boston). See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Advance Healthcare Management Institute](https://shizune.co/investors/profile/advance-healthcare-management-institute)
- Location: Boston, United States
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/martintolar

Martin Tolar is a startup investor at Advance Healthcare Management Institute in Boston. Martin Tolar has served as a Director of BELLUS Health since October 2010 and is currently the President and Chief Executive Officer of Alzheon, a private biotechnology company.From January 2012 to October 2012, Tolar was President and Chief Executive Officer of Knome, a private life science company. Before joining Knome, Dr. Tolar heldexecutive positions in pharmaceutical and biotechnology companies, including as Chief Executive Officer of NormOxys, where he successfully built and financed the business and advanced the company’s novel cancer therapeutics from a research project into clinical development. Prior to NormOxys, he was Chief Business Officer at CoMentis, where he led the company’s scientific and business growth and negotiated a landmark collaboration agreement with Astellas Pharma. Prior to CoMentis, Tolar held a variety of leadership positions at Pfizer in roles in clinical development and business development, in which he was instrumental in a wide range of business development transactions and directed programs through all stages of clinical development and NDA submissions. Prior to entering the private sector, Tolar was Assistant Professor in the Department of Neurology at Yale University School of Medicine.He trained in Neurology at the Boston Medical Center, received a PhD in Neuroscience, and published a number of scientific publications in the area of neuroscience and Alzheimer’s disease.Tolar was, until 2013, a member of the Board of Directors of Suven Life Sciences, a public biopharmaceutical company based in Hyderabad, India, focused on innovative drug development of novel first-in-class or best-in-class therapies through the use of GPCR targets.

## About Advance Healthcare Management Institute

VC Fund



1 contacts available at Advance Healthcare Management Institute.

| Name | Title | Profile |
| --- | --- | --- |
| Martin Tolar | Academic Board | https://shizune.co/investors/profile/martin-tolar |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co